文献速递复苏、休克与脓毒症儿科与产科急症重症综合管理与镇静镇痛

儿童院外心脏骤停复苏后首次动脉血二氧化碳分压与神经预后的关联:多中心回顾性队列研究

Association between the first post-resuscitation partial pressure of arterial carbon dioxide and neurologic outcomes in children with out-of-hospital cardiac arrest: a multicenter retrospective cohort study.
PubMed 文献 · Resuscitation · 2026-09-11
一句话结论儿童院外心脏骤停ROSC后60分钟内首次PaCO2分类与30天神经预后或生存无明确独立关联,但估计值不精确。

该多中心回顾性队列研究利用日本OHCA注册库(2014-2022),纳入<18岁ROSC后60分钟内完成首次血气采样的儿童OHCA患者215例,按首次ROSC后PaCO2分为低碳酸血症(<35 mmHg)、正常碳酸血症(35-45 mmHg)和高碳酸血症(>45 mmHg)。主要终点为30天良好神经预后(PCPC 1-3),次要终点为30天生存。经倾向评分重叠加权和医院聚类加权GEE模型调整后,低碳酸血症和高碳酸血症与良好神经预后及30天生存均无明确关联,但置信区间宽,估计不精确。

要点

  • 儿童OHCA患者ROSC后60分钟内首次PaCO2分类与30天良好神经预后无明确独立关联(低碳酸血症aOR 0.83,95%CI 0.13-5.14;高碳酸血症aOR 1.46,95%CI 0.25-8.68)。
  • 首次ROSC后PaCO2分类与30天生存亦无明确关联(低碳酸血症aOR 1.46,95%CI 0.26-8.01;高碳酸血症aOR 0.36,95%CI 0.09-1.46)。
  • 研究纳入215例患儿,其中低碳酸血症27例、正常碳酸血症39例、高碳酸血症149例;30天良好神经预后41例(19.1%),30天生存92例(42.8%)。
  • 因置信区间宽且样本量小,不能据此认为PaCO2异常无害,床旁仍应关注血气数值并结合临床。
  • 该研究为回顾性队列,仅提示无明确关联,不能确立因果关系或改变现有通气目标。

适用人群与场景

  • 日本OHCA注册库(2014-2022)中<18岁、院外心脏骤停后ROSC的儿童患者。
  • 主要分析限于ROSC后60分钟内完成首次血气采样的患者。

诊断标准与关键阈值

  • 按首次ROSC后PaCO2测量值分类:低碳酸血症<35 mmHg,正常碳酸血症35-45 mmHg,高碳酸血症>45 mmHg。
  • 良好神经预后定义为30天时儿科脑功能分类(PCPC)评分1-3。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 多中心回顾性队列研究,纳入215例儿童OHCA患者,来自日本OHCA注册库(2014-2022)。
  • 主要终点30天良好神经预后(PCPC 1-3)发生41例(19.1%),30天生存92例(42.8%)。
  • 以正常碳酸血症为参照,经倾向评分重叠加权和医院聚类加权GEE调整后,低碳酸血症与良好神经预后aOR 0.83(95%CI 0.13-5.14),高碳酸血症aOR 1.46(95%CI 0.25-8.68)。
  • 低碳酸血症与30天生存aOR 1.46(95%CI 0.26-8.01),高碳酸血症aOR 0.36(95%CI 0.09-1.46)。
  • 原文结论:无明确证据表明首次ROSC后PaCO2分类与30天结局独立关联,但估计值不精确。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:回顾性设计、样本量小(215例)、各组样本量不均(低碳酸血症27例、正常碳酸血症39例、高碳酸血症149例)、置信区间宽、估计不精确;原文未报告证据等级或推荐强度。

对床旁实践的改变

  • 该研究未发现首次ROSC后PaCO2分类与30天神经预后或生存的明确独立关联,不能据此改变儿童OHCA后通气管理目标。
  • 因估计值不精确且为回顾性设计,床旁不应将某一PaCO2分类视为无害或有益,仍需结合临床个体化评估。
  • 适用人群为<18岁OHCA且ROSC后60分钟内完成首次血气采样的患儿;不适用于未在60分钟内采样者或非OHCA儿童。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: The prognostic significance of the first post-ROSC PaCO2 in pediatric out-of-hospital cardiac arrest (OHCA) remains uncertain. We evaluated its association with 30-day outcomes.

METHODS: We conducted a multicenter retrospective cohort study using the Japanese OHCA registry (2014-2022). Pediatric patients aged <18 years with return of spontaneous circulation (ROSC) were included, and the primary analysis was restricted to patients with first post-ROSC blood gas sampling within 60 min. Patients were categorized as hypocapnia (<35 mmHg), normocapnia (35-45 mmHg), or hypercapnia (>45 mmHg) according to the first post-ROSC PaCO2 measurement. The primary outcome was favorable neurologic outcome at 30 days, defined as a Pediatric Cerebral Performance Category score of 1-3. The secondary outcome was 30-day survival. Associations were evaluated using multiple propensity score-based overlap weighting and hospital-clustered weighted generalized estimating equation models, with normocapnia as the reference.

RESULTS: Among 215 patients, 27 had hypocapnia, 39 normocapnia, and 149 hypercapnia. Favorable neurologic outcome at 30 days occurred in 41 (19.1%), and 30-day survival in 92 (42.8%). After adjustment, we found no clear evidence that either hypocapnia or hypercapnia was associated with favorable neurologic outcome (hypocapnia: adjusted odds ratio [aOR], 0.83; 95% confidence interval [CI], 0.13-5.14; hypercapnia: aOR, 1.46; 95% CI, 0.25-8.68) or 30-day survival (hypocapnia: aOR, 1.46; 95% CI, 0.26-8.01; hypercapnia: aOR, 0.36; 95% CI, 0.09-1.46).

CONCLUSIONS: In this multicenter study of pediatric OHCA, we found no clear evidence of an independent association between first post-ROSC PaCO2 category and 30-day outcomes, although estimates were imprecise.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Kikuchi N, Amagasa S, Moriwaki T, et al. Association between the first post-resuscitation partial pressure of arterial carbon dioxide and neurologic outcomes in children with out-of-hospital cardiac arrest: a multicenter retrospective cohort study. Resuscitation. 2026. PMID: 42727701. doi:10.1016/j.resuscitation.2026.111306

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。